Skip to main content

NASDAQ:CCRN - Cross Country Healthcare Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $10.67
  • Forecasted Upside: -36.88 %
  • Number of Analysts: 7
  • Breakdown:
  • 1 Sell Ratings
  • 3 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$16.90
▲ +0.79 (4.90%)
1 month | 3 months | 12 months
Get New Cross Country Healthcare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CCRN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CCRN

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$10.67
▼ -36.88% Downside Potential
This price target is based on 7 analysts offering 12 month price targets for Cross Country Healthcare in the last 3 months. The average price target is $10.67, with a high forecast of $13.50 and a low forecast of $7.50. The average price target represents a -36.88% upside from the last price of $16.90.

Hold

The current consensus among 7 polled investment analysts is to hold stock in Cross Country Healthcare. This rating has held steady since May 2020, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/16/2019
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
2/14/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/14/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
8/12/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 1 sell ratings
11/10/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 1 sell ratings
2/8/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 1 sell ratings
4/9/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 1 sell ratings
5/9/2021

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/6/2021Credit Suisse GroupBoost Price TargetNeutral$11.00 ➝ $13.50Medium
i
5/6/2021BenchmarkDowngradeBuy ➝ HoldHigh
i
3/3/2021Credit Suisse GroupBoost Price TargetNeutral$10.00 ➝ $11.00High
i
2/25/2021Credit Suisse GroupBoost Price TargetNeutral$10.00 ➝ $11.00High
i
2/22/2021Barrington ResearchReiterated RatingBuy$12.00Medium
i
11/23/2020BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$10.00Medium
i
11/5/2020Credit Suisse GroupBoost Price TargetNeutral$7.00 ➝ $8.50High
i
11/5/2020BMO Capital MarketsBoost Price TargetMarket Perform$7.00 ➝ $9.00Medium
i
11/5/2020BenchmarkUpgradeHold ➝ Buy$11.00High
i
10/30/2020TruistUpgradeHold ➝ Buy$7.00 ➝ $10.00High
i
10/8/2020Bank of AmericaInitiated CoverageUnderperform$7.50High
i
8/17/2020OppenheimerReiterated RatingHold ➝ NeutralMedium
i
8/12/2020Barrington ResearchReiterated RatingBuy$9.00Medium
i
Rating by K. Steinke at Barrington Research
8/6/2020Credit Suisse GroupBoost Price TargetNeutral$6.50 ➝ $7.00High
i
5/18/2020Barrington ResearchLower Price TargetOutperform$11.00 ➝ $9.00Medium
i
Rating by K. Steinke at Barrington Research
5/15/2020OppenheimerReiterated RatingHoldLow
i
5/8/2020SunTrust BanksLower Price TargetHold$9.00 ➝ $7.00Low
i
3/26/2020SunTrust BanksLower Price TargetHold$12.00 ➝ $9.00High
i
3/10/2020Barrington ResearchReiterated RatingOutperformHigh
i
Rating by K. Steinke at Barrington Research
5/20/2019Barrington ResearchSet Price TargetBuy$10.00Medium
i
Rating by Kevin Steinke at Barrington Research
2/28/2019BMO Capital MarketsLower Price TargetMarket Perform ➝ Market Perform$10.00 ➝ $8.00Medium
i
2/19/2019SunTrust BanksDowngradeBuy ➝ HoldHigh
i
11/15/2018Barrington ResearchSet Price TargetBuy$11.00Medium
i
Rating by Kevin Steinke at Barrington Research
11/5/2018BMO Capital MarketsBoost Price TargetMarket Perform ➝ Market Perform$9.00 ➝ $10.00High
i
11/2/2018Lake Street CapitalUpgradeHold ➝ Buy$10.00 ➝ $12.00High
i
10/2/2018StephensInitiated CoverageEqual WeightLow
i
9/19/2018Barrington ResearchSet Price TargetBuy$13.00Medium
i
Rating by Kevin Steinke at Barrington Research
8/9/2018Barrington ResearchReiterated RatingOutperformLow
i
Rating by Kevin Steinke at Barrington Research
8/2/2018Credit Suisse GroupLower Price TargetNeutral ➝ Neutral$11.50 ➝ $9.00High
i
8/2/2018BMO Capital MarketsDowngradeOutperform ➝ Market Perform$13.00High
i
8/1/2018Cantor FitzgeraldReiterated RatingNeutral ➝ Hold$11.00 ➝ $10.00High
i
Rating by J. France at Cantor Fitzgerald
5/22/2018Barrington ResearchReiterated RatingBuy$15.00Low
i
Rating by Kevin Steinke at Barrington Research
5/7/2018Cantor FitzgeraldReiterated RatingHold$11.00High
i
Rating by J. France at Cantor Fitzgerald
5/3/2018Lake Street CapitalDowngradeBuy ➝ Hold$16.00 ➝ $11.00High
i
Rating by B. O'neil at Lake Street Capital
4/18/2018Barrington ResearchInitiated CoverageOutperform$15.00Medium
i
Rating by K. Steinke at Barrington Research
3/6/2018BMO Capital MarketsReiterated RatingOutperform ➝ Outperform$14.00 ➝ $13.00Medium
i
3/2/2018Lake Street CapitalReiterated RatingBuy ➝ HoldHigh
i
Rating by B. O'neil at Lake Street Capital
3/2/2018Cantor FitzgeraldDowngradeOverweight ➝ NeutralHigh
i
Rating by J. France at Cantor Fitzgerald
3/2/2018SunTrust BanksReiterated RatingBuyHigh
i
3/1/2018BenchmarkDowngradeBuy ➝ Hold$19.00High
i
2/1/2018Jefferies Financial GroupInitiated CoverageHold ➝ Hold$15.00Low
i
11/7/2017Credit Suisse GroupInitiated CoverageNeutral ➝ Neutral$13.00N/A
i
11/6/2017BMO Capital MarketsLower Price TargetOutperform$15.00 ➝ $14.00N/A
i
11/1/2017Cantor FitzgeraldReiterated RatingBuy$18.00N/A
i
8/9/2017BenchmarkReiterated RatingBuy$18.00 ➝ $17.00Low
i
Rating by Bill Sutherland at Benchmark Co.
8/3/2017BenchmarkLower Price TargetBuy ➝ Buy$18.00 ➝ $17.00High
i
Rating by Bill Sutherland at Benchmark Co.
6/14/2017UBS GroupReiterated RatingBuy$16.50 ➝ $15.00N/A
i
5/15/2017BMO Capital MarketsLower Price TargetOutperform$18.00 ➝ $15.00N/A
i
5/5/2017BMO Capital MarketsLower Price TargetOutperform$18.00 ➝ $15.00Low
i
5/4/2017BenchmarkLower Price TargetBuy$19.00 ➝ $18.00High
i
4/5/2017BMO Capital MarketsReiterated RatingBuy$18.00Medium
i
2/15/2017Lake Street CapitalInitiated CoverageBuy$17.00N/A
i
1/24/2017Avondale PartnersDowngradeOutperform ➝ Market Perform$15.50N/A
i
Rating by R. Reece at Avondale Partners
1/20/2017BenchmarkInitiated CoverageBuy$19.00N/A
i
1/9/2017BMO Capital MarketsReiterated RatingBuy$17.00N/A
i
11/7/2016BMO Capital MarketsReiterated RatingBuyN/A
i
11/2/2016Cantor FitzgeraldSet Price TargetBuy$17.00N/A
i
Rating by Joseph France at Cantor Fitzgerald
9/15/2016UBS GroupSet Price TargetBuy$16.00N/A
i
Rating by a.j. rice at UBS Group AG
8/22/2016UBS GroupReiterated RatingBuyN/A
i
Rating by A.J. Rice at UBS Group AG
8/7/2016Cantor FitzgeraldReiterated RatingBuy$17.00N/A
i
Rating by Joseph France at Cantor Fitzgerald
8/5/2016BMO Capital MarketsReiterated RatingBuy$16.00N/A
i
7/26/2016UBS GroupReiterated RatingBuy$17.00N/A
i
Rating by A.J. Rice at UBS Group AG
7/17/2016Cantor FitzgeraldReiterated RatingBuyN/A
i
Rating by Joseph France at Cantor Fitzgerald
(Data available from 5/9/2016 forward)
Cross Country Healthcare logo
Cross Country Healthcare, Inc. provides talent management and other consultative services for healthcare clients in the United States. The company operates in three segments: Nurse and Allied Staffing, Physician Staffing, and Search. The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, branch-based local nurses, and allied staffing; short-term staffing of registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and travel allied professionals on long-term contract assignments, as well as workforce solutions, including MSP, OWS, RPO, IRP, EMR, and consulting services. It serves public and private acute care and non-acute care hospitals, government facilities, public and charter schools, outpatient clinics, ambulatory care facilities, physician practice groups, retailers, and other healthcare providers under the Cross Country brand. The Physician Staffing segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners, and physician assistants under the Cross Country Locums brand as independent contractors on temporary assignments at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations. The Search segment offers retained and contingent search services for physicians, healthcare executives, and other healthcare professionals, as well as recruitment process outsourcing. The company was founded in 1986 and is headquartered in Boca Raton, Florida.
Read More

Today's Range

Now: $16.90
$15.50
$17.26

50 Day Range

MA: $12.97
$11.87
$16.11

52 Week Range

Now: $16.90
$4.50
$17.34

Volume

444,222 shs

Average Volume

245,008 shs

Market Capitalization

$633.97 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.1

Frequently Asked Questions

What sell-side analysts currently cover shares of Cross Country Healthcare?

The following equities research analysts have issued stock ratings on Cross Country Healthcare in the last year: Bank of America Co., Barrington Research, Benchmark Co., BMO Capital Markets, Credit Suisse Group AG, Oppenheimer Holdings Inc., TheStreet, Truist, and Zacks Investment Research.
View the latest analyst ratings for CCRN.

What is the current price target for Cross Country Healthcare?

6 Wall Street analysts have set twelve-month price targets for Cross Country Healthcare in the last year. Their average twelve-month price target is $10.67, suggesting a possible downside of 36.9%. Credit Suisse Group AG has the highest price target set, predicting CCRN will reach $13.50 in the next twelve months. Bank of America Co. has the lowest price target set, forecasting a price of $7.50 for Cross Country Healthcare in the next year.
View the latest price targets for CCRN.

What is the current consensus analyst rating for Cross Country Healthcare?

Cross Country Healthcare currently has 1 sell rating, 3 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in CCRN, but not buy more shares or sell existing shares.
View the latest ratings for CCRN.

What other companies compete with Cross Country Healthcare?

Other companies that are similar to Cross Country Healthcare include Laboratory Co. of America, Quest Diagnostics, DaVita, Amedisys, Chemed, R1 RCM, LHC Group, AMN Healthcare Services, MEDNAX, CorVel and Tivity Health.

How do I contact Cross Country Healthcare's investor relations team?

Cross Country Healthcare's physical mailing address is 5201 CONGRESS AVENUE SUITE 100B, BOCA RATON FL, 33487. The business services provider's listed phone number is 561-998-2232 and its investor relations email address is [email protected] The official website for Cross Country Healthcare is www.crosscountryhealthcare.com.